Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

Eli Lilly is seeking FDA approval for tirzepatide for chronic weight management. The drug could be approved by the end of the year.

There’s already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

(Image credit: Eli Lilly & co.)

Read the full post on Health Care : NPR